EMPAGLIFLOZIN

undefined/100 · Low Risk

Manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.

100,203 FDA adverse event reports analyzed

Top Adverse Reactions

DIABETIC KETOACIDOSIS3,773 reports
NAUSEA3,212 reports
BLOOD GLUCOSE INCREASED3,043 reports
DIARRHOEA2,806 reports
WEIGHT DECREASED2,749 reports
FATIGUE2,590 reports
DIZZINESS2,417 reports
OFF LABEL USE2,407 reports
VOMITING2,399 reports
DRUG INEFFECTIVE2,181 reports
DYSPNOEA2,076 reports
FUNGAL INFECTION2,057 reports
EUGLYCAEMIC DIABETIC KETOACIDOSIS1,935 reports
URINARY TRACT INFECTION1,814 reports
HEADACHE1,680 reports
Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.